UBS Group’s SHL Telemedicine Ltd American Depositary Shares SHLT Stock Holding History

UBS Group’s Portfolio SHLT Stock Details SHLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,372	Closed	-$6.99K	–	11209
2025 Q1	$6.99K	Sell	3,372 -799	-19%	-$2.02K	﹤0.01%	8863
2024 Q4	$11.1K	Buy	4,171 +4,168	+138,933%	+$12K	﹤0.01%	8262
2024 Q3	$10	Sell	3 -2,156	-100%	-$8.54K	﹤0.01%	9361
2024 Q2	$11K	Buy	2,159 +2,070	+2,326%	+$10.9K	﹤0.01%	7666
2024 Q1	$543	Buy	+89	New	+$602	﹤0.01%	8491
2023 Q4	–	Sell	-141	Closed	-$1.55K	–	10047
2023 Q3	$1.55K	Buy	+141	New	+$1.35K	﹤0.01%	7896

Other funds holding SHLT

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

UBS Group's SHLT Position: Q2 2025 in Review

UBS Group sold out of SHL Telemedicine Ltd American Depositary Shares (SHLT) in Q2 2025, closing a stake of 3,372 shares — an estimated $6.99K sold.

UBS Group first reported a position in SHLT in Q3 2023 and held it in 6 quarters. The position peaked at $11.1K in Q4 2024. 1 fund tracked by Wall St. Rank holds SHLT as of Q2 2025.

UBS Group reported no remaining SHL Telemedicine Ltd American Depositary Shares position as of Q2 2025 after selling out during the quarter.
UBS Group sold 3,372 SHL Telemedicine Ltd American Depositary Shares shares in Q2 2025, an estimated $6.99K.
UBS Group first reported a position in SHL Telemedicine Ltd American Depositary Shares in Q3 2023 and held it in 6 quarters.
UBS Group's SHL Telemedicine Ltd American Depositary Shares position peaked at $11.1K in Q4 2024.
1 fund tracked by Wall St. Rank held SHL Telemedicine Ltd American Depositary Shares as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.